HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS

被引:0
|
作者
Koka, N. S. [1 ]
Syed, A. A. [1 ]
Ahmad, M. [1 ]
Patel, K. [1 ]
Nair, S. [1 ]
Shah, S. [1 ]
机构
[1] Market Access Solut LLC LTD MKTXS, Raritan, NJ USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA169
引用
收藏
页码:S329 / S329
页数:1
相关论文
共 50 条
  • [31] ASSESSMENT OF HEALTH TECHNOLOGY APPRAISALS TO IDENTIFY KEY DRIVERS FOR REIMBURSEMENT OF ONCOLOGY DRUGS WITH ONLY PHASE 2 CLINICAL DATA
    Duran, A.
    Morlock, R.
    Lie, X.
    Dekkers, R.
    Gani, R.
    van Engen, A.
    Holmstrom, S.
    VALUE IN HEALTH, 2017, 20 (09) : A471 - A471
  • [32] Use of health technology assessment in drug reimbursement decisions in China
    Chen, Wen
    Zhang, Luying
    Hu, Min
    Hu, Shanlian
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [33] Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
    Drummond, Michael
    Joensson, Bengt
    Rutten, Frans
    Stargardt, Tom
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (03): : 263 - 271
  • [34] Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
    Michael Drummond
    Bengt Jönsson
    Frans Rutten
    Tom Stargardt
    The European Journal of Health Economics, 2011, 12 : 263 - 271
  • [35] PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA
    Benisheva-Dimitrova, Tatyana
    Sidjimova, Dobriana
    Cherneva, Daniela
    Kralimarkov, Nikolay
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (03) : 365 - 370
  • [36] COMPARISON OF ONCOLOGY THERAPY REIMBURSEMENT RECOMMENDATIONS MADE BY HEALTH TECHNOLOGY ASSESSMENT AGENCIES IN AUSTRALIA, CANADA, SWEDEN, AND UNITED KINGDOM
    Samjoo, I. A.
    Grima, D. T.
    VALUE IN HEALTH, 2014, 17 (03) : A101 - A101
  • [37] THE ASSESSMENT OF ALTERNATIVE OR ABBREVIATED MARKET ACCESS PATHWAYS FOR PHARMACEUTICAL REIMBURSEMENT IN 13 EUROPEAN MARKETS
    Martinez, Schepis J.
    Falk, K.
    Solanke, O.
    Van den Eynde, K.
    Tuominen, E.
    Torriani, A.
    da Silva, Pestana M.
    Sanchez-Martin, J.
    Bostrom, A. K.
    Labori, F.
    Garnham, A.
    Watts-James, J.
    VALUE IN HEALTH, 2023, 26 (12) : S274 - S275
  • [38] Health technology assessment for gene therapies in haemophilia
    O'Hara, Jamie
    Neumann, Peter J.
    HAEMOPHILIA, 2022, 28 : 19 - 26
  • [39] REIMBURSEMENT OF TARGETED CANCER THERAPIES WITHIN THREE DIFFERENT EUROPEAN HEALTH CARE SYSTEMS
    Mihajlovic, J.
    Dolk, C.
    Postma, M. J.
    VALUE IN HEALTH, 2014, 17 (07) : A658 - A659
  • [40] TRENDS IN CANADIAN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT
    Groff, M.
    Hwang, S.
    Daniele, P.
    Tremblay, G.
    VALUE IN HEALTH, 2021, 24 : S52 - S52